Carmichael Hill & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $148K | Sell |
2,860
-536
| -16% | -$27.7K | 0.05% | 197 |
|
2024
Q2 | $141K | Buy |
3,396
+100
| +3% | +$4.15K | 0.06% | 194 |
|
2024
Q1 | $179K | Hold |
3,296
| – | – | 0.07% | 181 |
|
2023
Q4 | $169K | Sell |
3,296
-424
| -11% | -$21.8K | 0.07% | 173 |
|
2023
Q3 | $216K | Hold |
3,720
| – | – | 0.1% | 141 |
|
2023
Q2 | $238K | Sell |
3,720
-948
| -20% | -$60.6K | 0.11% | 138 |
|
2023
Q1 | $324K | Buy |
4,668
+310
| +7% | +$21.5K | 0.16% | 108 |
|
2022
Q4 | $314K | Hold |
4,358
| – | – | 0.16% | 105 |
|
2022
Q3 | $310K | Buy |
4,358
+250
| +6% | +$17.8K | 0.17% | 106 |
|
2022
Q2 | $316K | Hold |
4,108
| – | – | 0.17% | 107 |
|
2022
Q1 | $300K | Hold |
4,108
| – | – | 0.14% | 117 |
|
2021
Q4 | $256K | Hold |
4,108
| – | – | 0.11% | 127 |
|
2021
Q3 | $243K | Hold |
4,108
| – | – | 0.12% | 122 |
|
2021
Q2 | $274K | Sell |
4,108
-811
| -16% | -$54.1K | 0.14% | 115 |
|
2021
Q1 | $311K | Hold |
4,919
| – | – | 0.17% | 107 |
|
2020
Q4 | $305K | Hold |
4,919
| – | – | 0.18% | 102 |
|
2020
Q3 | $297K | Hold |
4,919
| – | – | 0.2% | 97 |
|
2020
Q2 | $289K | Hold |
4,919
| – | – | 0.21% | 91 |
|
2020
Q1 | $274K | Hold |
4,919
| – | – | 0.24% | 81 |
|
2019
Q4 | $316K | Buy |
+4,919
| New | +$316K | 0.22% | 86 |
|
2018
Q4 | – | Sell |
-3,798
| Closed | -$236K | – | 108 |
|
2018
Q3 | $236K | Hold |
3,798
| – | – | 0.23% | 100 |
|
2018
Q2 | $210K | Sell |
3,798
-388
| -9% | -$21.5K | 0.23% | 101 |
|
2018
Q1 | $265K | Hold |
4,186
| – | – | 0.29% | 90 |
|
2017
Q4 | $257K | Buy |
+4,186
| New | +$257K | 0.28% | 88 |
|